The Global Cannabis Stock Index fell for the 12th consecutive month, declining 1.1% to 28.31, reported Alan Brochstein, founder of New Cannabis Ventures and 420 Investor.
The index, which was down 27% in Q4 and then fell 12.9% in January, had 38 qualifying members during the month. The index has declined 13.8% in 2022, noted Brochstein.
After increasing 5.2% in 2020, it fell 26.0% in 2021 to 32.85 and has declined 69.4% from its 2021 closing high of 92.48 on February 10, 2021.
After posting an all-time closing low of 16.95 set on March 18, 2020, the index remains 67.0% higher but still down 84.3% from its early 2018 closing high at 180.02:
The strongest 4 names in February all gained at least 13%:
- IM Cannabis IMCC IMCC: +30.3%
- Flora Growth FLGC: +19.9%
- WM Technology MAPS: +15.4%
- Cresco Labs CL CRLBF: +13.5%
IM Cannabis bounced back, said Brochstein, from a difficult January when it was among the weakest names. Flora Growth, which started as a $5 IPO in May 2021, is now up in 2022 but down 59% since its IPO. WM Technology rallied after its Q4 financial report, with revenue exceeding analysts' expectations. Cresco Labs has been the strongest Tier 1 MSO thus far in 2022, rallying nearly 5%.
The 4 weakest names in February all declined by more than 17%:
- Greenlane GNLN: -29.1%
- iPower IPW: -23.1%
- Power REIT PW: -22.8%
- cbdMD YCBD: -17.3%
Brochstein noted that the three weakest names are from the ancillary sector, which has been under pressure in 2022. Greenlane has declined 44.0% year-to-date, iPower has lost 37.0%, and Power REIT has dropped 30.0%. cbdMD fell sharply after reporting its Q1 financials and is down 20.4% in 2022.
Photo by Christine Roy on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.